top TOP
February 1, 2022

Eran Meshorer, PhD

Hebrew University

ICRF Project Grant Recipient

Eran Meshorer, PhD of Hebrew University of Jerusalem, received an ICRF Project Grant for his project entitled, “Histone Turnover in Glioblastoma.” Glioblastoma (GBM) is the most common malignant brain tumor, and it is challenging to treat. A single mutation occurs frequently in a type of GBM that occurs only in pediatric patients. These experiments should identify specific mechanisms by which this mutation may drive malignancy, and potentially identify pathways for therapeutic intervention.

View Grant Recipient profile

Help End the Suffering Caused By Cancer

The answer to cancer is research. Support groundbreaking cancer research in Israel today: